Tamoxifen beyond 5 years - Patients' decisions regarding entry to the aTTom trial

European Journal of Cancer

Volumn 38, Issue 14, 2002, Pages 1857-1859

  Ferguson, M J ^a   Dewar, J A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

aTTom; Patient and clinician equipoise; Tamoxifen

Indexed keywords

TAMOXIFEN;

ARTICLE; CANCER; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFORMED CONSENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DECISION MAKING; FEMALE; HUMANS; PATIENT COMPLIANCE; TAMOXIFEN; TIME FACTORS;

EID: 0036710824     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00220-4     Document Type: Article

References (11)

1. Baum M. New approach for recruitment into randomised controlled trials. clinical trials are ethically impossible Lancet. 341:1993;812-813.
2. Early Breast Cancer Trialists' Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet. 339:1992;1-15, 71-85.
3. Early Breast Cancer Trialists' Collaborative Group Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 351:1998;1451-1467.
4. The Swedish Breast Cancer Co-Operative Group Randomised trial of two versus five years of adjuvant tamoxifen for post menopausal early stage breast cancer. J. Natl. Cancer Inst. 88:1996;1543-1549.
5. Current Trials Working Party of the CRC Breast Cancer Trials Group Preliminary results from the Cancer Research Campaign trial evaluating tamoxifen duration in women aged fifty years and older with breast cancer. J. Natl. Cancer Inst. 88:1996;1834-1839.
6. Peto R. Editorial. J. Natl. Cancer Inst. 88:1996;1791-1793.
7. Llewellyn-Thomas H.A., McGreal M.J., Thiel E.C., Fine S., Erlich-man C. Patients' willingness to enter clinical trials. measuring the association with perceived benefits and preference for decision participation Soc. Sci. Med. 32:1991;35-42.
8. Fallowfield L.J., Jenkins V., Brennan C., Sawtell M., Moynihan C., Souhami R.L. Attitudes of patients to randomised clinical trials of cancer therapy. Eur. J. Cancer. 34:1998;1554-1559.
9. Jenkins V.A., Fallowfield L.J., Souhami A., Sawtell M. How do doctors explain randomised clinical trials to their patients? Eur. J. Cancer. 35:1999;1187-1193.
10. Slevin M., Mossman J., Bowling A.et al. Volunteers or victims. patients' views of randomised cancer clinical trials Br. J. Cancer. 71:1995;1270-1274.
11. Thornton H. The voice of the breast cancer patient - a lonely cry in the wilderness. Eur. J. Cancer. 33:1997;825-828.